Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment
In a first-of-its-kind initiative, TissUse (a leader in organ-on-chip technology) announced the commencement of the Live…
TissUse GmbH
New Multi-Organ-Chip project towards vaccine & drug candidate testing for Tuberculosis
TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph no…
Philip Morris International and TissUse develop a human aerosol test platform to emulate the entire human respiratory tract
PMI and TissUse have signed a collaboration agreement to utilize PMI’s InHALES technology in combination with TissUse’s…
TissUse GmbH appoints Dr. Reyk Horland as new CEO while TissUse's founder
On its 10th company anniversary, TissUse GmbH appoints Dr. Reyk Horland, previously VP Business Development, as the new…
TissUse has been certified under the ISO EN 9001-2015
TissUse – the leading pioneer of the Multi-Organ-Chips technology enabling highly predictive substance testing has been…
TissUse Launches New Product Brand HUMIMIC
TissUse, the Berlin-based pioneers in Human-on-a-Chip developments, have launched their new product brand HUMIMIC. From…
TissUse launcht neue Produktmarkte HUMIMIC
TissUse, die Berliner Pioniere in Human-on-a-Chip Entwicklungen haben Ihre Produktmarke HUMIMIC gelauncht. Unter diesem…
TissUse grants first Smart Hair Transplant (SHT) License in Japan
For the first time, TissUse has granted development and distribution rights of its existing Smart Hair Transplant (SHT)…
TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer
TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay usi…
TissUse announces new partnership with leading pharmaceutical company to develop applications for its Multi-Organ-Chip platform in drug research and development
TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi…
